Cargando…

Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review

The microenvironment plays an essential role in multiple myeloma (MM) development, progression, cell proliferation, survival, immunological escape, and drug resistance. Mesenchymal stromal cells and macrophages release tolerogenic cytokines and favor anti-apoptotic signaling pathway activation, whil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manzo, Paola, Giudice, Valentina, Napolitano, Filomena, De Novellis, Danilo, Serio, Bianca, Moscato, Paolo, Montuori, Nunzia, Selleri, Carmine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Hypothesis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341390/ https://www.ncbi.nlm.nih.gov/pubmed/37445697 http://dx.doi.org/10.3390/ijms241310519

Ejemplares similares

Plasminogen System in the Pathophysiology of Sepsis: Upcoming Biomarkers
por: Napolitano, Filomena, et al.
Publicado: (2023)

Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer
por: Montuori, Nunzia, et al.
Publicado: (2016)

Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance
por: De Novellis, Danilo, et al.
Publicado: (2022)

The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors
por: Rossi, Francesca Wanda, et al.
Publicado: (2016)

Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma
por: Giudice, Valentina, et al.
Publicado: (2022)

The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis
por: Napolitano, Filomena, et al.
Publicado: (2021)

Role of Plasminogen Activation System in Platelet Pathophysiology: Emerging Concepts for Translational Applications
por: Napolitano, Filomena, et al.
Publicado: (2022)

Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment
por: Selleri, Carmine, et al.
Publicado: (2016)

The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications
por: Li Santi, Anna, et al.
Publicado: (2021)

67 kDa laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach?
por: Montuori, Nunzia, et al.
Publicado: (2016)

Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells
por: Alfano, Daniela, et al.
Publicado: (2015)

The Value of Flow Cytometry Clonality in Large Granular Lymphocyte Leukemia
por: Giudice, Valentina, et al.
Publicado: (2021)

Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
por: De Novellis, Danilo, et al.
Publicado: (2022)

A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A
por: De Novellis, Danilo, et al.
Publicado: (2022)

Soluble Urokinase Receptor as a Promising Marker for Early Prediction of Outcome in COVID-19 Hospitalized Patients
por: Napolitano, Filomena, et al.
Publicado: (2021)

N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor
por: Napolitano, Filomena, et al.
Publicado: (2018)

In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)

Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors
por: Mauro, Concetta Di, et al.
Publicado: (2017)

Homology modeling of Mycoplasma pneumoniae enolase and its molecular interaction with human plasminogen
por: Chumchua, Vasunun, et al.
Publicado: (2008)

Efficacy of Decitabine and Venetoclax as Salvage and Bridge Therapy to Haploidentical Hematopoietic Stem Cell Transplantation in a Multiresistant Acute Myeloid Leukemia Patient
por: Serio, Bianca, et al.
Publicado: (2022)

P1544: IMPACT OF SARS-COV 2 INFECTION, IN TREATED NHL-B AND HD, AFTER VACCINATION AND PREVENTIVE THERAPY WITH ANTIBODIES: OUR EXPERIENCE
por: Pezzullo, Luca, et al.
Publicado: (2023)

Multiple myeloma presented as acute renal failure
por: Momeni, Ali, et al.
Publicado: (2013)

Shear stress modulates macrophage-induced urokinase plasminogen activator expression in human chondrocytes
por: Yeh, Chih-Chang, et al.
Publicado: (2013)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Giudice, Valentina, et al.
Publicado: (2021)

Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens
por: Pezzullo, Luca, et al.
Publicado: (2021)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia
por: Giudice, Valentina, et al.
Publicado: (2016)

Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation
por: Parente, Roberta, et al.
Publicado: (2023)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Immunological Derangement in Hypocellular Myelodysplastic Syndromes
por: Serio, B, et al.
Publicado: (2014)

P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE
por: Pezzullo, Luca, et al.
Publicado: (2023)

Urokinase Plasminogen Activator Induces Pro-Fibrotic/M2 Phenotype in Murine Cardiac Macrophages
por: Meznarich, Jessica, et al.
Publicado: (2013)

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Publicado: (1987)

Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse
Publicado: (1984)

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
por: Lee, Ji-Hye, et al.
Publicado: (2014)

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type
Publicado: (1986)

A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs
por: Li Santi, Anna, et al.
Publicado: (2018)

Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
por: Heynekamp, Justin J, et al.
Publicado: (2006)

Overexpression of urokinase-type plasminogen activator in pterygia and pterygium fibroblasts
por: Chao, Shih-Chun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4fijh0tkim46bbfn18m0qj1lc2